3 Medical Device Stocks With Solid Potential To Buy Now

The company’s estimate revision trend for the current year has been encouraging. In the past 60 days, one analyst moved up with no movement in the opposite direction. The magnitude of estimate revision increased around 10% to 44 cents per share over the same time frame.

Baxter International (BAX - Free Report) is a global medical technology company. The company’s impressive product pipeline is a key catalyst. Baxter recently launched a new version of its AK 98 hemodialysis (HD) system to help dialysis providers minimize the operational challenges associated with hemodialysis.

A glimpse at the price performance of the stock reveals that Baxter added 16.8% over the last three months. Additionally, the company’s estimate revision trend for the current year has been rising. In the past 60 days, nine analysts moved up with no movement in the opposite direction. The magnitude of estimate revision increased around 5% to $2.27 per share over the same time frame.

Baxter also achieved a regulatory milestone for its advanced dialysis technology. The company received guidance from the FDA clearing the regulatory pathway for its home peritoneal dialysis (PD) solution system.

 

1 2 3
View single page >> |

Disclosure: Zacks.com contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or completeness. References to any specific ...

more
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.